Why the study?
Radiofrequency catheter ablation is effective for AF, but AF recurrence remains a problem, prompting evaluation of whether a deep convolutional neural network can accurately predict recurrence compared with conventional statistical analysis.
Does a deep convolutional neural network (CNNSurv) model improve prediction of atrial fibrillation recurrence in patients with AF who underwent RFCA compared to conventional statistical analysis?
Does a deep convolutional neural network (CNNSurv) model improve prediction of atrial fibrillation recurrence in patients with AF who underwent RFCA compared to conventional statistical analysis?
A deep learning-based survival model (CNNSurv) using NT-proBNP, AF type, LAAV, and LAV outperforms conventional statistical methods in predicting AF recurrence after catheter ablation.
Answers are grounded in this paper and cite their sources.
CNN may enhance post-RFCA AF recurrence prediction; leaves open prospective validation and clinical utility.
BACKGROUND: Radiofrequency catheter ablation (RFCA) is an effective therapy for atrial fibrillation (AF). However, it the problem of AF recurrence remains. This study investigates whether a deep convolutional neural network (CNN) can accurately predict AF recurrence in patients with AF who underwent RFCA, and compares CNN with conventional statistical analysis. METHODS AND RESULTS: Three-hundred and ten patients with AF after RFCA treatment, including 94 patients with AF recurrence, were enrolled. Nine variables are identified as candidate predictors by univariate Cox proportional hazards regression (CPH). A CNNSurv model for AF recurrence prediction was proposed. The model's discrimination ability is validated by a 10-fold cross validation method and measured by C-index. After back elimination, 4 predictors are used for model development, they are N-terminal pro-BNP (NT-proBNP), paroxysmal AF (PAF), left atrial appendage volume (LAAV) and left atrial volume (LAV). The average testing C-index is 0.76 (0.72-0.79). The corresponding calibration plot appears to fit well to a diagonal, and the P value of the Hosmer-Lemeshow test also indicates the proposed model has good calibration ability. The proposed model has superior performance compared with the DeepSurv and multivariate CPH. The result of risk stratification indicates that patients with non-PAF, higher NT-proBNP, larger LAAV and LAV would have higher risks of AF recurrence. CONCLUSIONS: The proposed CNNSurv model has better performance than conventional statistical analysis, which may provide valuable guidance for clinical practice.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: